![if gte IE 9]> <![endif]>
LIBTAYO is NOW APPROVED in combination with
chemotherapy to treat certain types of advanced lung cancer.
For a type of lung cancer called non–small cell lung cancer (NSCLC) in adults that has spread to other areas of your body or has not spread outside of your chest and cannot be treated with surgery, and your tumor does not have an abnormal “EGFR,” “ALK,” or “ROS1” gene. LIBTAYO can be used in combination with chemotherapy or used alone:
For a type of skin cancer called
cutaneous squamous cell carcinoma
(CSCC) that has spread or cannot be
cured by surgery or radiation.
Add the LIBTAYO Surround contact number to your mobile phone,
so you don’t miss our call if you sign up!
LIBTAYO Surround: 1.877.LIBTAYO (1.877.542.8296)
ALK=anaplastic lymphoma kinase; EGFR=epidermal growth factor receptor; HHI=hedgehog pathway inhibitor; PD-L1=programmed death ligand 1; ROS1=ROS proto-oncogene 1,
receptor tyrosine kinase.